Press Release

News Archive

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area

AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area Read press release at CISION PR Newswire San Francisco, CA February 5, 2018 – AbbVie, a global biopharmaceutical company, and MBC BioLabs (formerly known as QB3@953), a life-science incubator, announced that they have teamed up to help support and mentor promising startups.  The partnership […]

Read more

QB3@953 Unites Life-Science Facility Under New MBC BioLabs Name

QB3@953 Unites Life-Science Facility Under New MBC BioLabs Name San Francisco, CA (February 5, 2018) – QB3@953 to become MBC BioLabs with the addition of a brand-new facility in San Carlos. QB3@953, an independent provider of innovative shared laboratory space located at 953 Indiana St. in San Francisco, was born out of the California Institute for Quantitative Biosciences, a three-campus […]

Read more

Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases

Japanese chemical firm Toray partners with QB3@953 to pursue breakthroughs in treatment of neurological diseases San Francisco, CA, May 11, 2017 – QB3@953, the Bay Area’s premier life science incubator, welcomes Japan’s chemical giant Toray as its newest partner. The arrangement offers Toray the opportunity to nurture its budding pharmaceutical enterprise while bringing new expertise and trans-Pacific relationships to QB3@953’s […]

Read more

AMGEN and QB3@953 announce winners of the AMGEN GOLDEN TICKET

AMGEN AND QB3@953 ANNOUNCE WINNERS OF THE AMGEN GOLDEN TICKET San Francisco, CA, June 11, 2017 – Two Diagnostic Companies Will Receive Lab Space and Other Benefits at San Francisco Life Sciences Incubator Amgen (NASDAQ: AMGN) and QB3@953 today announced that Darmiyan and Enable Biosciences have won the Amgen Golden Ticket at QB3@953. Each company receives one year of lab […]

Read more

QB3@953 Companies Attract $1.36B In Capital

QB3@953 Companies Attract $1.36B In Capital San Francisco, CA, May 1, 2017 – QB3@953 proved definitively that its incubator facilities allow life science startups to progress at lightening speed, making a huge impact on the life-science ecosystem of the Bay Area. QB3@953 tenant and alumni companies are thriving. In the three short years since its founding, QB3@953 companies attracted $1.36Bn […]

Read more

QB3@953 facilitates strategic alliance between innovative start up member and a sponsor company

QB3@953 facilitates strategic alliance between innovative start up member and a sponsor company Telo Therapeutics enters into an Oncology-focused research collaboration with GSK San Francisco, CA, Feb 2, 2017 – QB3@953, the Bay Area’s premier life science incubator, today announced the collaboration between one of its member companies, Telo Therapeutics, and one of its sponsor companies, GlaxoSmithKline (GSK). Telo Therapeutics […]

Read more

Perlara PBC Announces Pharma Collaboration with Novartis

Perlara PBC Announces Pharma Collaboration with Novartis SAN FRANCISCO, Oct. 19, 2016 /PRNewswire/ Perlara PBC (previously Perlstein Lab PBC) today announced the formation of a drug discovery and development collaboration with Novartis to identify new definitive therapeutics for lysosomal storage disorders, starting with lead program Niemann-Pick Type C Disease. In addition to the collaboration, Novartis has made an equity investment […]

Read more

Amgen Incubators Grow Startup for Harvest

Amgen Incubators Grow Startup for Harvest Venture division seeks access to technology, potential takeovers. San Fernando Valley Business Journal, July 11-24, 2016 By STEPHANIE HENKEL, Staff Reporter Amgen inc. hopes to get in on more ground floors by sponsoring startups in the biotech hubs in Cambridge, Mass. and, more recently, in San Francisco. The Thousand Oaks biopharmaceutical company last month […]

Read more

Kite Pharma and Cell Design Labs Announce Exclusive Research Collaboration

Kite Pharma and Cell Design Labs Announce Exclusive Research Collaboration Using Molecular ‘On/Off Switches’ for CAR T-Cell Immunotherapies Kite to License Cell Design Labs’ Synthetic Biology Technology for Applications in Acute Myeloid Leukemia with Exclusive Option for Applications in B-cell Malignancies Cell Design Labs’ Reversible ‘On/Off Switch’ Technology Provides Dynamic Range of Control to Precisely Regulate Activity of Engineered CAR […]

Read more

Cell Design Labs Executes Series of Private Financings

Cell Design Labs Executes Series of Private Financings New Company Focused on Discovering and Developing Next-Generation Immunotherapies for Cancer and Other Complex Diseases   SAN FRANCISCO, Calif. June 2, 2016 — Cell Design Labs, Inc. today announced it has executed a staged series of investor and strategic partner financings totaling $34.4 million to fund the company’s start-up operations. The investors, […]

Read more
Page 1 of 212

Upcoming Event

  • Office Hours with WSGR Patent and Corporate Law

    09:00-11:00
    03/01/2018
    To apply for Office Hours contact: Carol Ochoa Sponsored by:
    Ali Alemozafar Dr. Ali R. Alemozafar is a senior associate at Wilson Sonsini Goodrich & Rosati, where he focuses on patent prosecution, strategic patent counseling, and IP due diligence in a wide range of technical fields, including diagnostics, therapeutics, genomics, and materials. Ali received his Ph.D. in chemical engineering at Stanford University, where he investigated the reactivity and atomic-scale changes accompanying reactions on various catalysts. During his postdoctoral research fellowship at the Department of Chemistry and Chemical Biology at Harvard University, he investigated the dynamics of TiOx nanoparticles and the use of gold as an oxidation catalyst. Prior to attending law school, Ali worked on data warehousing, business intelligence, and enterprise data integration. Ali frequently lectures at the UC Berkeley School of Law and UC Hastings College of the Law on various intellectual property topics, including patent strategy and IP due diligence. Michael Hostetler Dr. Mike Hostetler is a partner in the SOMA and San Diego offices of Wilson Sonsini Goodrich & Rosati, where he provides strategic intellectual property counseling to more than 100 growth enterprises in the pharmaceutical and biotechnology, and information technology industries. He works with both venture-backed and public companies. His expertise includes patent strategy, patent prosecution, and patent diligence (both buy and sell side) for venture financings, public offerings, and mergers and acquisitions. He has provided patent counseling in support of pharmaceutical and biotechnology, and information technology products in all stages of development, from proof of concept to regulatory approval to product launch. He leads a talented team of patent associates and patent agents that can meet virtually any technical and strategic need. Mike currently serves as a member of the firm's Policy and Nominating Committees. Elton Satusky Elton Satusky is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati. He specializes in public and private corporate finance and corporate law and governance. Elton also has considerable expertise in the areas of mergers and acquisitions and venture capital.

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter